Sen. Chuck Grassley (R-IA) headshot
U.S. Sen. Chuck Grassley (R-Iowa) wants to know if HHS will impose civil monetary penalties on drug companies that deny 340B pricing over multiple contract pharmacy.

Sen. Grassley Presses HHS OIG to Punish Drug Makers Over Denials of 340B Pricing

Senate Finance Committee ranking Republican Chuck Grassley (Iowa) yesterday asked the U.S. Health and Human Services Department of Inspector General (OIG) if it plans to punish seven drug companies over their denials of 340B pricing when hospitals, health centers, and clinics use contract pharmacies.

Grassley has had a hand in the 340B program perhaps longer and more consistently than any other current member of Congress. He led a well-publicized investigation into hospitals participating in the 340B program several years ago but has also raised concerns about drug manufacturer actions.

Senate Finance Committee ranking Republican Chuck Grassley (Iowa) yesterday asked the U.S. Health and Human Services Department of Inspector General (OIG) if it plans to punish seven drug companies over their denials of 340B pricing when hospitals, health centers, and clinics use contract pharmacies.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer